Asthma drug can block crucial SARS-CoV-2 protein - EurekAlert

Montelukast, an FDA-approved drug, can bind strongly to and block the activity of a SARS-CoV-2 protein called Nsp1

image: Targeting Nsp1 with montelukast helps prevent shutdown of host protein synthesisview more  Credit: Mohammad Afsar A drug used to treat asthma and allergies can bind to and block a crucial pr… [+3872 chars]

full article...